Partnership will allow hospitals easier access to integrated
suites of diagnostic imaging modalities, advanced informatics and
services for comprehensive breast screening and diagnosis
AMSTERDAM and MARLBOROUGH, Massachusetts, March 2, 2018 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global
leader in health technology, and Hologic, Inc. (Nasdaq: HOLX), an
innovative women's health company, announced today a global
partnership agreement to offer care professionals integrated
solutions comprising diagnostic imaging modalities, advanced
informatics and services for screening, diagnosis and treatment of
women across the world. The collaboration combines Hologic's
innovative mammography technologies and Philips' leading portfolio
of ultrasound, MRI, CT, and X-ray systems, advanced informatics and
broad range of services, including maintenance, upgrade, training
and operational performance management services.
"No two women are alike, and we are teaming up with care
providers and leading industry partners to support the delivery of
a tailored, seamless breast care experience for women," said said
Rob Cascella, CEO Diagnosis &
Treatment businesses for Royal
Philips. "That is why I am very pleased to announce our new
partnership with Hologic for mammography. This partnership allows
us to offer a complete set of innovative diagnostic imaging
systems, software and services to our customers, including
Hologic's market-leading mammography solutions for breast screening
and diagnosis of women in need of care."
"Hologic believes in enabling doctors with superior technology
that improves women's health through early detection and
treatment," said Pete Valenti,
Hologic's Division President, Breast and Skeletal Health Solutions.
"Our market-leading mammography solutions perfectly complement
Philips' portfolio, making Hologic the right industry partner for
this first-of-its-kind collaboration. Now, through the partnership,
Hologic can join Philips when engaging with customers on projects
that were not previously possible for the two companies alone. It's
a win for everyone involved, including the customers and patients
we serve."
In breast care, Philips offers advanced imaging for ultrasound
(e.g. Philips Affinity with Anatomical Intelligence for Breast),
MRI (e.g. Philips Ingenia digital MRI with Compressed SENSE to
speed up exam times), and PET/CT (e.g. Philips Vereos fully digital
PET/CT), supported by intelligent image analysis, quantification,
information management and workflow tools. Under the agreement,
Philips will be able to offer select products from Hologic's breast
health portfolio as part of multi-modality deals for hospitals and
health systems. This will include Hologic's new 3Dimensions™
mammography system, the fastest, highest resolution breast
tomosynthesis system in the industry, as well as other technologies
for breast screening and interventional radiology [1,2].
The multi-year, non-exclusive global partnership agreement
allows for customized regional implementation to best meet the
individual needs of each customer. The financial details of the
agreement were not disclosed.
To learn more about the 3Dimensions system and its comprehensive
range of features, which are compatible with all Hologic 3D
Mammography™ systems, visit 3DimensionsSystem.com. Hologic will
feature its full breast health portfolio, including the new
3Dimensions system, at the 2018 European Congress of Radiology
(ECR) at booth #211 in X2 at the Austria Center in
Vienna.
Philips will also showcase its full suite of solutions for
diagnosis and treatment at ECR 2018 booth #402 in
X4. For more information about Philips' presence at ECR 2018,
including its virtual reality MR experience, visit
www.philips.com/ecr, and follow @PhilipsLiveFrom for #ECR18 live
updates.
[1]
|
Hologic Data on
file
|
[2]
|
Pending FDA
approval and/or commercial availability
|
For further information, please contact:
Joost Maltha
Philips Group Press Office
Tel.: +31 6 10 55 8116
E-mail: joost.maltha@philips.com
Twitter: @JoostMaltha
Jane Mazur
Hologic
Tel.: +1 508 263 8764 (direct)
Tel.: +1 585 355 5978 (mobile)
E-mail: jane.mazur@hologic.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA)
is a leading health technology company focused on improving
people's health and enabling better outcomes across the health
continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips' health
technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 74,000
employees with sales and services in more than 100 countries. News
about Philips can be found
at http://www.philips.com/newscenter.
About Hologic, Inc.
Hologic, Inc. is an innovative
medical technology company primarily focused on improving women's
health and well-being through early detection and treatment. For
more information on Hologic, visit www.hologic.com.
Hologic, 3Dimensions and 3D Mammography is a trademark of
Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.
Forward-Looking Statements
This news release
may contain forward-looking information that involves risks and
uncertainties, including statements about the use of Hologic
products. There can be no assurance these products will achieve the
benefits described herein or that such benefits will be replicated
in any particular manner with respect to an individual patient, as
the actual effect of the use of the products can only be determined
on a case-by-case basis. In addition, there can be no assurance
that these products will be commercially successful or achieve any
expected level of sales. Hologic expressly disclaims any obligation
or undertaking to release publicly any updates or revisions to any
such statements presented herein to reflect any change in
expectations or any change in events, conditions or circumstances
on which any such data or statements are based.
This information is not intended as a product solicitation or
promotion where such activities are prohibited. For specific
information on what products are available for sale in a particular
country, please contact a local Hologic sales representative or
write to womenshealth@hologic.com.
Photo -
https://mma.prnewswire.com/media/648903/Hologic___mammography.jpg
Photo -
https://mma.prnewswire.com/media/648904/Hologic_and_Philips.jpg